75% of severe blood cancers cured in Iran through cellular grafting

Submitted by MNA on

TEHRAN, April 23 (MNA) - About 75 percent of malignant and benign blood cancers as well as genetic and metabolic disease are being treated through cellular grafting in Iran.

The full content of this page is available to premium users only. You can contact us to gain premium access to full texts, high resoluton photos and videos at tsalci@aa.com.tr

iran
severe blood cancers
cellular grafting